BiVictriX Therapeutics makes 'fundamental step forward' | News Direct

BiVictriX Therapeutics makes 'fundamental step forward'

BlueRush Inc.
Digital Asset Direct by BlueRush Inc.

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | January 22, 2023 07:55 AM Eastern Standard Time

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) founder and CEO Tiffany Thorn speaks to Proactive about the "completely new approach" the company has been pioneering within the realm of oncology. She reveals more details about the "fundamental step" that BiVictrix has taken recently. Thorn also lays out her vision for the long-term future of the company.

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

project media

Tags

biotechcancerbloodcancerr&ddrugdevelopmenttargettreatment